Our Progress (Keep an Eye)

Our progress to date includes:

• We redesigned preprocessing workflows and reduced preparation time from approximately 9 hours to ~2 hours in our current development system.

• Selective Recovery Validation

• We demonstrated early-stage structure-dependent recovery of higher-integrity collagen fractions.

• Characterization studies completed for collagen I (FTIR + Control Assays + CD Spec)

• Rheological studies begin shortly.

Purification Infrastructure:

We built a tangential flow filtration (TFF)-based downstream system to improve purity, consistency, and repeatability

Scale-up Logic:

We mapped a reactor → module → pilot architecture, creating a path toward distributed, scalable manufacturing from 100 kg/year → 2.2 tons/year

Market Pull:

We have received early interest from labs and users who need dependable collagen inputs for advanced applications.

We have initiated 3rd party validation protocol setup with SRM.

Why This Matters:

• When critical materials become better, entire industries move faster.

• Cheaper computing accelerated software.

• Better batteries accelerated electric mobility.

• Reliable cloud infrastructure accelerated startups.

We believe reliable biomaterials can accelerate the future of healthcare in the same way.

If collagen becomes faster to produce, more consistent, and more accessible:

• Researchers iterate faster

• Biomaterial startups reduce costs

• New products become viable

• Advanced healthcare becomes easier to build

We are marching briskly towards our goal and are aligning partners with our Vision!